Can personalized medicine contribute to prevention and control of NCDs in the Russian Federation?
14 May 2018, St Petersburg, Russian Federation
On 14 May 2018, the WHO European Office for the Prevention and Control of Noncommunicable Diseases (NCD Office), in collaboration with the Ministry of Health of the Russian Federation, will host a meeting on “Personalized medicine and opportunities for the prevention and control of NCDs” in St Petersburg, Russian Federation. Outcomes of the meeting will include a situation analysis of personalized medicine in the Russian Federation and points for future action at a national level.
The meeting will bring together relevant stakeholders from the Russian Federation and the WHO European Region to discuss the potential of innovative personalized medicine tools for the country’s fight against NCDs.
Personalized medicine refers to a medical model that uses the characterization of individuals’ phenotypes and genotypes to tailor therapeutic strategies for the right person at the right time, to determine predisposition to disease and to deliver timely and targeted prevention. Genomic and nongenomic biomarkers should enable the identification of patients who are more likely to respond to therapy and those most likely to experience side effects.
Some argue that personalized medicine is an approach to health care that puts the person at the centre, allowing tailored strategies for diagnosis, treatment and prevention. Others contend that it has the potential to widen inequalities. Experts and WHO representatives will discuss whether this approach could fit within WHO’s advocacy for more people-centred health care, which lies at the heart of the European health policy framework Health 2020.